Pharma & Biotech

While Nautilus Biotechnology's stock has faced substantial selling pressure for months, a significant development has emerged from the executive suite....

A notable divergence has emerged at Recursion Pharmaceuticals between the actions of corporate insiders and the outlook of Wall Street...

The biotechnology sector is currently weathering a severe sell-off, and BioNTech SE finds itself at the center of the storm....

Tenet Healthcare's stock performance continues to impress investors, propelled by exceptional quarterly results and overwhelmingly positive analyst sentiment. However, beneath...

Neurocrine Biosciences is capturing significant attention from both the medical community and investors. The biotechnology firm is generating excitement with...

The investment narrative surrounding Crinetics Pharmaceuticals presents a complex puzzle for market participants. On one hand, institutional money is flowing...

Ultragenyx Pharmaceutical finds itself navigating turbulent market conditions, with its equity value experiencing a dramatic contraction of over fifty percent...

Pfizer finds itself navigating increasingly turbulent political waters as it works to reduce its reliance on COVID-related products. Simultaneous regulatory...

Nuvalent finds itself at a pivotal crossroads as the biotech company balances promising clinical developments against recent market uncertainties. Investors...

Investors in Agios Pharmaceuticals faced a sharp selloff after US regulators announced a three-month delay for the approval decision of...